CNSX:LXX - Lexaria Bioscience Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.62 -0.12 (-6.90 %)
(As of 07/18/2018 07:00 AM ET)
Previous Close$1.74
Today's Range$1.59 - $1.70
52-Week Range$0.27 - $2.54
Volume184,580 shs
Average Volume250,001 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive LXX News and Ratings via Email

Sign-up to receive the latest news and ratings for LXX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange CNSX
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolCNSX:LXX
CUSIPN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares70,320,000
Market Cap$0.00

The Truth About Cryptocurrencies

Lexaria Bioscience (CNSX:LXX) Frequently Asked Questions

What is Lexaria Bioscience's stock symbol?

Lexaria Bioscience trades on the CNSX under the ticker symbol "LXX."

What price target have analysts set for LXX?

1 analysts have issued 1 year target prices for Lexaria Bioscience's stock. Their predictions range from $4.64 to $4.64. On average, they expect Lexaria Bioscience's stock price to reach $4.64 in the next twelve months. This suggests a possible upside of 186.4% from the stock's current price. View Analyst Ratings for Lexaria Bioscience.

What is the consensus analysts' recommendation for Lexaria Bioscience?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Lexaria Bioscience in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."

Has Lexaria Bioscience been receiving favorable news coverage?

News coverage about LXX stock has been trending positive this week, Accern reports. Accern ranks the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Lexaria Bioscience earned a media sentiment score of 0.46 on Accern's scale. They also gave press coverage about the company an impact score of 46.22 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

How do I buy shares of Lexaria Bioscience?

Shares of LXX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Lexaria Bioscience's stock price today?

One share of LXX stock can currently be purchased for approximately $1.62.


MarketBeat Community Rating for Lexaria Bioscience (CNSX LXX)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  21 (Vote Outperform)
Underperform Votes:  13 (Vote Underperform)
Total Votes:  34
MarketBeat's community ratings are surveys of what our community members think about Lexaria Bioscience and other stocks. Vote "Outperform" if you believe LXX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LXX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.